Covalent Targeting of Fibroblast Growth Factor Receptor Inhibits Metastatic Breast Cancer.
about
Integrins in the Spotlight of CancerFGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition.Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib.Regulation of epithelial-mesenchymal transition and metastasis by TGF-β, P-bodies, and autophagy.Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells.The paradoxical functions of EGFR during breast cancer progression
P2860
Covalent Targeting of Fibroblast Growth Factor Receptor Inhibits Metastatic Breast Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Covalent Targeting of Fibrobla ...... bits Metastatic Breast Cancer.
@en
type
label
Covalent Targeting of Fibrobla ...... bits Metastatic Breast Cancer.
@en
prefLabel
Covalent Targeting of Fibrobla ...... bits Metastatic Breast Cancer.
@en
P2093
P2860
P1476
Covalent Targeting of Fibroblast Growth Factor Receptor Inhibits Metastatic Breast Cancer
@en
P2093
Andrew Smith
Nathanael S Gray
Wells S Brown
P2860
P304
P356
10.1158/1535-7163.MCT-16-0136
P577
2016-07-01T00:00:00Z